PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Diabetes Technology & Therapeutics10.1089/dia.2022.01482022Prospective Open-Label, Single-Arm, Single-Center Follow-Up Study of the Application of the Advanced Hybrid Closed Loop System in Well-Controlled Children and Adolescents with Type 1 DiabetesSebastian Seget, Ewa Rusak, Joanna Polanska, Przemysława Jarosz-Chobothttps://www.liebertpub.com/doi/full-xml/10.1089/dia.2022.0148, https://www.liebertpub.com/doi/pdf/10.1089/dia.2022.0148
Clinical Pharmacology: Advances and Applications10.2147/cpaa.s54809201463Glibenclamide in patients with poorly controlled type 2 diabetes: a 12-week, prospective, single-center, open-label, dose-escalation studyPoobalan Naidoo, Virendra Rambiritch, Brumy Maharajhttps://www.dovepress.com/getfile.php?fileID=19558
Diabetes & Metabolism Journal10.4093/dmj.2013.37.3.2122013373212Letter: Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm Study (Diabetes Metab J2013;37:117-24)Byung-Wan Leehttps://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2013.37.3.212, https://synapse.koreamed.org/pdf/10.4093/dmj.2013.37.3.212, http://e-dmj.org/upload/pdf/dmj-37-212.pdf
Diabetes Therapy10.1007/s13300-021-01123-w202112102807-2811Correction to: Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory TrialHiroaki Seinohttps://link.springer.com/content/pdf/10.1007/s13300-021-01123-w.pdf, https://link.springer.com/article/10.1007/s13300-021-01123-w/fulltext.html, https://link.springer.com/content/pdf/10.1007/s13300-021-01123-w.pdf
Diabetology International10.1007/s13340-018-0359-x201810137-50Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a 36-week, open-label extension of a 16-week, randomized, placebo-controlled, double-blind studyHisamitsu Ishihara, Susumu Yamaguchi, Ikko Nakao, Seitaro Asahina, Taishi Sakatanihttp://link.springer.com/article/10.1007/s13340-018-0359-x/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13340-018-0359-x.pdf, http://link.springer.com/content/pdf/10.1007/s13340-018-0359-x.pdf
Diabetes Therapy10.1007/s13300-017-0247-6201783611-621Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm StudyYujing Jin, Xiaowei Sun, Xichen Zhao, Tiehong Zhuhttp://link.springer.com/content/pdf/10.1007/s13300-017-0247-6.pdf, http://link.springer.com/article/10.1007/s13300-017-0247-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13300-017-0247-6.pdf
Diabetes Therapy10.1007/s13300-021-01014-02021123863-877Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory TrialHiroaki Seinohttps://link.springer.com/content/pdf/10.1007/s13300-021-01014-0.pdf, https://link.springer.com/article/10.1007/s13300-021-01014-0/fulltext.html, https://link.springer.com/content/pdf/10.1007/s13300-021-01014-0.pdf
Diabetes Therapy10.1007/s13300-017-0260-9201783623-624Erratum to: Adding Prandial Insulin to Basal Insulin Plus Oral Antidiabetic Drugs in Chinese Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Single-Arm StudyYujing Jin, Xiaowei Sun, Xichen Zhao, Tiehong Zhuhttp://link.springer.com/content/pdf/10.1007/s13300-017-0260-9.pdf, http://link.springer.com/article/10.1007/s13300-017-0260-9/fulltext.html, http://link.springer.com/content/pdf/10.1007/s13300-017-0260-9.pdf
Diabetes, Obesity and Metabolism10.1111/dom.122352013165418-425Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extensionT. Kadowaki, K. Kondohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fdom.12235, http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12235/fullpdf
Diabetes & Metabolism Journal10.4093/dmj.2013.37.2.1172013372117Efficacy and Safety of Biphasic Insulin Aspart 30/70 in Type 2 Diabetes Suboptimally Controlled on Oral Antidiabetic Therapy in Korea: A Multicenter, Open-Label, Single-Arm StudyKee-Ho Song, Jung Min Kim, Jung-Hyun Noh, Yongsoo Park, Hyun-Shik Son, Kyong Wan Min, Kyung Soo Kohttps://synapse.koreamed.org/DOIx.php?id=10.4093/dmj.2013.37.2.117, https://synapse.koreamed.org/pdf/10.4093/dmj.2013.37.2.117, http://e-dmj.org/upload/pdf/dmj-37-117.pdf